Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022 Tenon is focused on three commercial opportunities with its System in the SI Joint market, which includes: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) SI Joint fusion adjunct to a spine fusion construct. For more information, please visit https://www.tenonmed.com/.
![Tenon Medical logo](/files/LOGO/1560293-TNON.png)
Company profile
Ticker
TNON
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
455574718
TNON stock data
Latest filings (excl ownership)
S-1/A
IPO registration (amended)
20 Jun 24
POS AM
Prospectus update (post-effective amendment)
20 Jun 24
POS AM
Prospectus update (post-effective amendment)
20 Jun 24
DEF 14A
Definitive proxy
13 Jun 24
POS AM
Prospectus update (post-effective amendment)
11 Jun 24
PRE 14A
Preliminary proxy
3 Jun 24
8-K
Departure of Directors or Certain Officers
22 May 24
10-Q
2024 Q1
Quarterly report
14 May 24
S-1
IPO registration
10 May 24
POS AM
Prospectus update (post-effective amendment)
10 May 24
Transcripts
TNON
Earnings call transcript
2024 Q1
14 May 24
TNON
Earnings call transcript
2023 Q4
12 Mar 24
TNON
Earnings call transcript
2023 Q3
14 Nov 23
TNON
Earnings call transcript
2023 Q2
8 Aug 23
TNON
Earnings call transcript
2023 Q1
9 May 23
TNON
Earnings call transcript
2022 Q4
9 Mar 23
TNON
Earnings call transcript
2022 Q3
10 Nov 22
Latest ownership filings
SC 13G
TMD Wealth Management, LLC
16 Apr 24
3
Kristine M Jacques
29 Mar 24
SC 13G/A
TMD Wealth Management, LLC
14 Feb 24
5
DICK STEVEN M VAN
13 Feb 24
5
STEVEN M FOSTER
13 Feb 24
5
RICHARD GINN
13 Feb 24
SC 13G/A
TMD Wealth Management, LLC
13 Sep 23
4
DICK STEVEN M VAN
15 Jun 23
4
Richard Ferrari
24 May 23
4
Stephen Hochschuler
24 May 23
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 4.39 mm | 4.39 mm | 4.39 mm | 4.39 mm | 4.39 mm | 4.39 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.17 mm | 1.20 mm | 779.33 k | 912.08 k |
Cash used (since last report) | n/a | n/a | 3.26 mm | 3.34 mm | 2.17 mm | 2.55 mm |
Cash remaining | n/a | n/a | 1.13 mm | 1.05 mm | 2.21 mm | 1.84 mm |
Runway (months of cash) | n/a | n/a | 1.0 | 0.9 | 2.8 | 2.0 |
Institutional ownership, Q4 2023
65.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 16 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 52.90 mm |
Total shares | 2.45 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Ventures AG Zuhlke | 2.45 mm | $52.90 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jun 23 | Dick Steven M Van | Common Stock | Buy | Acquire P | No | No | 0.273 | 50,000 | 13.65 k | 100,416 |
23 May 23 | Richard Ginn | Common Stock | Sell | Dispose S | No | No | 1.26 | 64,990 | 81.89 k | 85,318 |
23 May 23 | Steven M Foster | Common Stock | Sell | Dispose S | No | No | 1.26 | 27,791 | 35.02 k | 44,686 |
22 May 23 | Richard Ginn | Common Stock | Option exercise | Acquire M | No | No | 1.62 | 150,308 | 243.50 k | 150,308 |
22 May 23 | Steven M Foster | Common Stock | Option exercise | Acquire M | No | No | 1.62 | 72,477 | 117.41 k | 72,477 |
22 May 23 | Stephen Hochschuler | Common Stock | Option exercise | Acquire M | No | No | 1.62 | 6,207 | 10.06 k | 25,907 |
News
12 Health Care Stocks Moving In Monday's Pre-Market Session
20 May 24
Tenon Medical Q1 2024 GAAP EPS $(1.25) Beats $(1.34) Estimate, Sales $719.00K Miss $783.00K Estimate
14 May 24
Benchmark Maintains Speculative Buy on Tenon Medical, Lowers Price Target to $3
15 Apr 24
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
3 Apr 24
Tenon Medical Announces Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran SI Joint Fusion System
26 Mar 24